|
2025-02-18 |
2025-02-14 |
V
Vente
|
Herr Amy E.
Administrateur non-exécutif
|
1 860
-48.5%
65,96
122 691 USD
|
1 860
-48.5%
|
65,96
|
122 691 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
Kelderman Kim
Chief Executive Officer
Administrateur exécutif
|
1 661
-4.1%
77,95
129 480 USD
|
1 661
-4.1%
|
77,95
|
129 480 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
Kelderman Kim
Chief Executive Officer
Administrateur exécutif
|
11 731
-22.4%
77,19
905 533 USD
|
11 731
-22.4%
|
77,19
|
905 533 USD
|
|
|
2024-08-12 |
2024-08-08 |
V
Vente
|
BAUMGARTNER ROBERT V
Administrateur non-exécutif
|
16 000
-26.9%
72,10
1 153 664 USD
|
16 000
-26.9%
|
72,10
|
1 153 664 USD
|
|
|
2024-05-16 |
2024-05-14 |
V
Vente
|
HIGGINS JOHN L
Administrateur non-exécutif
|
4 000
-9.9%
83,84
335 377 USD
|
4 000
-9.9%
|
83,84
|
335 377 USD
|
|
|
2024-03-11 |
2024-03-07 |
V
Vente
|
Nusse Roeland
Administrateur non-exécutif
|
10 400
-19.4%
76,98
800 627 USD
|
10 400
-19.4%
|
76,98
|
800 627 USD
|
|
|
2023-09-01 |
2023-08-30 |
V
Vente
|
Nusse Roeland
Administrateur non-exécutif
|
8 939
-14.7%
80,32
717 959 USD
|
8 939
-14.7%
|
80,32
|
717 959 USD
|
|
|
2023-07-25 |
2023-07-21 |
VP
Vente planifiée
|
Kummeth Charles R.
Chief Executive Officer
Administrateur exécutif
|
80 000
-6.0%
88,36
7 069 024 USD
|
80 000
-6.0%
|
88,36
|
7 069 024 USD
|
|
|
2023-06-09 |
2023-06-07 |
V
Vente
|
Kummeth Charles R.
Chief Executive Officer
Administrateur exécutif
|
322
-0.0%
83,00
26 726 USD
|
322
-0.0%
|
83,00
|
26 726 USD
|
|
|
2022-12-09 |
2022-12-08 |
V
Vente
|
Furlow Brenda S.
SVP - GENERAL COUNSEL
Dirigeant
|
7 450
-22.2%
82,12
611 810 USD
|
7 450
-22.2%
|
82,12
|
611 810 USD
|
|
|
2022-12-09 |
2022-12-07 |
V
Vente
|
Furlow Brenda S.
SVP - GENERAL COUNSEL
Dirigeant
|
800
-3.0%
82,01
65 605 USD
|
800
-3.0%
|
82,01
|
65 605 USD
|
|
|
2022-08-12 |
2022-08-11 |
V
Vente
|
HIGGINS JOHN L
Administrateur non-exécutif
|
8
-0.1%
380,71
3 046 USD
|
8
-0.1%
|
380,71
|
3 046 USD
|
|
|
2022-08-12 |
2022-08-11 |
V
Vente
|
HIGGINS JOHN L
Administrateur non-exécutif
|
504
-8.4%
385,47
194 277 USD
|
504
-8.4%
|
385,47
|
194 277 USD
|
|
|
2022-08-12 |
2022-08-10 |
V
Vente
|
HIGGINS JOHN L
Administrateur non-exécutif
|
992
-14.2%
380,15
377 112 USD
|
992
-14.2%
|
380,15
|
377 112 USD
|
|
|
2022-08-12 |
2022-08-10 |
V
Vente
|
HIGGINS JOHN L
Administrateur non-exécutif
|
100
-1.4%
374,90
37 490 USD
|
100
-1.4%
|
374,90
|
37 490 USD
|
|
|
2022-08-12 |
2022-08-10 |
V
Vente
|
HIGGINS JOHN L
Administrateur non-exécutif
|
900
-11.2%
373,99
336 593 USD
|
900
-11.2%
|
373,99
|
336 593 USD
|
|
|
2022-06-09 |
2022-06-08 |
V
Vente
|
HIGGINS JOHN L
Administrateur non-exécutif
|
600
-11.5%
366,09
219 654 USD
|
600
-11.5%
|
366,09
|
219 654 USD
|
|
|
2022-06-09 |
2022-06-07 |
V
Vente
|
Kummeth Charles R.
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
5 104
-2.5%
365,00
1 862 960 USD
|
5 104
-2.5%
|
365,00
|
1 862 960 USD
|
|
|
2022-06-09 |
2022-06-07 |
V
Vente
|
HIGGINS JOHN L
Administrateur non-exécutif
|
1 000
-17.8%
364,31
364 310 USD
|
1 000
-17.8%
|
364,31
|
364 310 USD
|
|
|
2022-05-11 |
2022-05-10 |
A
Achat
|
BAUMGARTNER ROBERT V
Administrateur non-exécutif
|
300
+3.1%
352,55
105 765 USD
|
300
+3.1%
|
352,55
|
105 765 USD
|
|
|
2021-11-23 |
2021-11-19 |
V
Vente
|
Kelderman Kim
Pres. Diagnostics & Genom
Dirigeant
|
400
-100.0%
505,78
202 313 USD
|
400
-100.0%
|
505,78
|
202 313 USD
|
|
|
2021-11-23 |
2021-11-19 |
V
Vente
|
Kelderman Kim
Pres. Diagnostics & Genom
Dirigeant
|
100
-20.0%
503,76
50 376 USD
|
100
-20.0%
|
503,76
|
50 376 USD
|
|
|
2021-11-16 |
2021-11-12 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
401
-23.3%
506,24
203 002 USD
|
401
-23.3%
|
506,24
|
203 002 USD
|
|
|
2021-11-16 |
2021-11-12 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
2 535
-59.6%
505,49
1 281 407 USD
|
2 535
-59.6%
|
505,49
|
1 281 407 USD
|
|
|
2021-11-16 |
2021-11-12 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
8 989
-67.9%
504,39
4 533 985 USD
|
8 989
-67.9%
|
504,39
|
4 533 985 USD
|
|
|
2021-11-16 |
2021-11-12 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
9 043
-40.6%
503,61
4 554 137 USD
|
9 043
-40.6%
|
503,61
|
4 554 137 USD
|
|
|
2021-11-16 |
2021-11-12 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
4 054
-15.4%
502,77
2 038 221 USD
|
4 054
-15.4%
|
502,77
|
2 038 221 USD
|
|
|
2021-11-16 |
2021-11-12 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
400
-1.5%
505,01
202 002 USD
|
400
-1.5%
|
505,01
|
202 002 USD
|
|
|
2021-11-16 |
2021-11-12 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
537
-2.0%
504,14
270 725 USD
|
537
-2.0%
|
504,14
|
270 725 USD
|
|
|
2021-11-16 |
2021-11-12 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
300
-1.1%
502,99
150 897 USD
|
300
-1.1%
|
502,99
|
150 897 USD
|
|
|
2021-11-16 |
2021-11-12 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
200
-0.7%
504,78
100 956 USD
|
200
-0.7%
|
504,78
|
100 956 USD
|
|
|
2021-11-16 |
2021-11-12 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
700
-2.5%
504,09
352 860 USD
|
700
-2.5%
|
504,09
|
352 860 USD
|
|
|
2021-11-03 |
2021-11-02 |
VP
Vente planifiée
|
Hippel James
Chief Financial Officer
Dirigeant
|
200
-1.8%
525,10
105 020 USD
|
200
-1.8%
|
525,10
|
105 020 USD
|
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Hippel James
Chief Financial Officer
Dirigeant
|
943
-8.1%
528,55
498 427 USD
|
943
-8.1%
|
528,55
|
498 427 USD
|
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Hippel James
Chief Financial Officer
Dirigeant
|
1 433
-10.9%
527,50
755 903 USD
|
1 433
-10.9%
|
527,50
|
755 903 USD
|
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Hippel James
Chief Financial Officer
Dirigeant
|
2 880
-18.0%
526,50
1 516 321 USD
|
2 880
-18.0%
|
526,50
|
1 516 321 USD
|
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Hippel James
Chief Financial Officer
Dirigeant
|
3 566
-18.2%
525,61
1 874 318 USD
|
3 566
-18.2%
|
525,61
|
1 874 318 USD
|
|
|
2021-11-01 |
2021-10-29 |
VP
Vente planifiée
|
Hippel James
Chief Financial Officer
Dirigeant
|
662
-5.8%
525,23
347 704 USD
|
662
-5.8%
|
525,23
|
347 704 USD
|
|
|
2021-11-01 |
2021-10-28 |
VP
Vente planifiée
|
Hippel James
Chief Financial Officer
Dirigeant
|
100
-0.9%
525,18
52 518 USD
|
100
-0.9%
|
525,18
|
52 518 USD
|
|
|
2021-09-02 |
2021-08-31 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
1 538
-53.9%
503,07
773 728 USD
|
1 538
-53.9%
|
503,07
|
773 728 USD
|
|
|
2021-09-02 |
2021-08-31 |
V
Vente
|
Furlow Brenda S.
SVP - General Counsel
Dirigeant
|
3 108
-29.0%
506,12
1 573 011 USD
|
3 108
-29.0%
|
506,12
|
1 573 011 USD
|
|
|
2021-09-02 |
2021-08-31 |
V
Vente
|
Furlow Brenda S.
SVP - General Counsel
Dirigeant
|
1 569
-12.8%
505,26
792 755 USD
|
1 569
-12.8%
|
505,26
|
792 755 USD
|
|
|
2021-09-02 |
2021-08-31 |
V
Vente
|
Furlow Brenda S.
SVP - General Counsel
Dirigeant
|
323
-2.6%
503,24
162 546 USD
|
323
-2.6%
|
503,24
|
162 546 USD
|
|
|
2021-08-10 |
2021-08-09 |
V
Vente
|
Hippel James
Chief Financial Officer
Dirigeant
|
300
-2.7%
484,98
145 494 USD
|
300
-2.7%
|
484,98
|
145 494 USD
|
|
|
2021-08-10 |
2021-08-09 |
V
Vente
|
Hippel James
Chief Financial Officer
Dirigeant
|
300
-2.6%
483,62
145 085 USD
|
300
-2.6%
|
483,62
|
145 085 USD
|
|
|
2021-08-10 |
2021-08-09 |
V
Vente
|
Hippel James
Chief Financial Officer
Dirigeant
|
300
-2.6%
481,61
144 482 USD
|
300
-2.6%
|
481,61
|
144 482 USD
|
|
|
2021-08-10 |
2021-08-09 |
V
Vente
|
Hippel James
Chief Financial Officer
Dirigeant
|
700
-5.6%
480,66
336 462 USD
|
700
-5.6%
|
480,66
|
336 462 USD
|
|
|
2021-08-10 |
2021-08-09 |
V
Vente
|
Hippel James
Chief Financial Officer
Dirigeant
|
100
-0.8%
480,70
48 070 USD
|
100
-0.8%
|
480,70
|
48 070 USD
|
|
|
2021-08-10 |
2021-08-09 |
V
Vente
|
Hippel James
Chief Financial Officer
Dirigeant
|
1 300
-9.4%
479,96
623 954 USD
|
1 300
-9.4%
|
479,96
|
623 954 USD
|
|
|
2021-08-10 |
2021-08-09 |
V
Vente
|
Hippel James
Chief Financial Officer
Dirigeant
|
1 800
-11.5%
478,58
861 444 USD
|
1 800
-11.5%
|
478,58
|
861 444 USD
|
|
|
2021-08-10 |
2021-08-09 |
V
Vente
|
Hippel James
Chief Financial Officer
Dirigeant
|
5 200
-24.9%
477,69
2 484 002 USD
|
5 200
-24.9%
|
477,69
|
2 484 002 USD
|
|
|
2021-06-21 |
2021-06-18 |
VP
Vente planifiée
|
Kummeth Charles R.
Chief Executive Officer
Administrateur exécutif
|
326
-0.2%
450,37
146 821 USD
|
326
-0.2%
|
450,37
|
146 821 USD
|
|
|
2021-06-21 |
2021-06-18 |
VP
Vente planifiée
|
Kummeth Charles R.
Chief Executive Officer
Administrateur exécutif
|
2 583
-1.6%
449,09
1 159 999 USD
|
2 583
-1.6%
|
449,09
|
1 159 999 USD
|
|
|
2021-06-21 |
2021-06-17 |
VP
Vente planifiée
|
Kummeth Charles R.
Chief Executive Officer
Administrateur exécutif
|
109
-0.1%
452,13
49 282 USD
|
109
-0.1%
|
452,13
|
49 282 USD
|
|
|
2021-06-21 |
2021-06-17 |
VP
Vente planifiée
|
Kummeth Charles R.
Chief Executive Officer
Administrateur exécutif
|
1 050
-0.7%
451,54
474 117 USD
|
1 050
-0.7%
|
451,54
|
474 117 USD
|
|
|
2021-06-21 |
2021-06-17 |
VP
Vente planifiée
|
Kummeth Charles R.
Chief Executive Officer
Administrateur exécutif
|
1 698
-1.1%
450,39
764 762 USD
|
1 698
-1.1%
|
450,39
|
764 762 USD
|
|
|
2021-06-21 |
2021-06-17 |
VP
Vente planifiée
|
Kummeth Charles R.
Chief Executive Officer
Administrateur exécutif
|
6 732
-4.0%
449,35
3 025 024 USD
|
6 732
-4.0%
|
449,35
|
3 025 024 USD
|
|
|
2021-06-16 |
2021-06-14 |
VP
Vente planifiée
|
Kummeth Charles R.
Chief Executive Officer
Administrateur exécutif
|
349
-0.2%
450,10
157 085 USD
|
349
-0.2%
|
450,10
|
157 085 USD
|
|
|
2021-06-16 |
2021-06-14 |
VP
Vente planifiée
|
Kummeth Charles R.
Chief Executive Officer
Administrateur exécutif
|
7 132
-4.1%
449,10
3 202 981 USD
|
7 132
-4.1%
|
449,10
|
3 202 981 USD
|
|
|
2021-02-17 |
2021-02-12 |
V
Vente
|
Furlow Brenda S.
SVP - General Counsel
Dirigeant
|
3 326
-35.2%
399,12
1 327 461 USD
|
3 326
-35.2%
|
399,12
|
1 327 461 USD
|
|
|
2021-02-17 |
2021-02-12 |
V
Vente
|
Furlow Brenda S.
SVP - General Counsel
Dirigeant
|
6 674
-41.4%
398,40
2 658 891 USD
|
6 674
-41.4%
|
398,40
|
2 658 891 USD
|
|
|
2021-02-17 |
2021-02-12 |
V
Vente
|
Hippel James
Chief Financial Officer
Dirigeant
|
600
-6.2%
401,52
240 911 USD
|
600
-6.2%
|
401,52
|
240 911 USD
|
|
|
2021-02-17 |
2021-02-12 |
V
Vente
|
Hippel James
Chief Financial Officer
Dirigeant
|
9 400
-49.1%
400,32
3 762 998 USD
|
9 400
-49.1%
|
400,32
|
3 762 998 USD
|
|
|
2021-02-10 |
2021-02-08 |
V
Vente
|
Nusse Roeland
Administrateur non-exécutif
|
6 000
-47.0%
385,08
2 310 481 USD
|
6 000
-47.0%
|
385,08
|
2 310 481 USD
|
|
|
2021-02-09 |
2021-02-05 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
1 100
-45.5%
385,59
424 151 USD
|
1 100
-45.5%
|
385,59
|
424 151 USD
|
|
|
2021-02-09 |
2021-02-05 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
1 900
-44.0%
384,15
729 888 USD
|
1 900
-44.0%
|
384,15
|
729 888 USD
|
|
|
2021-02-09 |
2021-02-05 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
3 700
-46.1%
382,60
1 415 636 USD
|
3 700
-46.1%
|
382,60
|
1 415 636 USD
|
|
|
2021-02-09 |
2021-02-05 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
2 900
-26.6%
381,52
1 106 395 USD
|
2 900
-26.6%
|
381,52
|
1 106 395 USD
|
|
|
2021-02-09 |
2021-02-05 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
12 833
-54.0%
380,50
4 882 918 USD
|
12 833
-54.0%
|
380,50
|
4 882 918 USD
|
|
|
2021-02-09 |
2021-02-05 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
4 500
-15.9%
379,62
1 708 312 USD
|
4 500
-15.9%
|
379,62
|
1 708 312 USD
|
|
|
2021-02-09 |
2021-02-05 |
V
Vente
|
Eansor Norman David
President-Protein Sciences
Dirigeant
|
6 000
-17.5%
378,29
2 269 723 USD
|
6 000
-17.5%
|
378,29
|
2 269 723 USD
|
|
|
2021-02-09 |
2021-02-05 |
V
Vente
|
Kelderman Kim
Pres. Diagnostics & Genom
Dirigeant
|
823
-49.3%
388,45
319 694 USD
|
823
-49.3%
|
388,45
|
319 694 USD
|
|
|
2021-01-20 |
2021-01-15 |
VP
Vente planifiée
|
Kummeth Charles R.
Chief Executive Officer
Administrateur exécutif
|
20 000
-12.0%
344,00
6 880 000 USD
|
20 000
-12.0%
|
344,00
|
6 880 000 USD
|
|
|
2021-01-13 |
2021-01-11 |
VP
Vente planifiée
|
Hippel James
Chief Financial Officer
Dirigeant
|
2 009
-18.0%
334,98
672 983 USD
|
2 009
-18.0%
|
334,98
|
672 983 USD
|
|
|
2021-01-13 |
2021-01-11 |
VP
Vente planifiée
|
Hippel James
Chief Financial Officer
Dirigeant
|
3 990
-26.4%
334,39
1 334 219 USD
|
3 990
-26.4%
|
334,39
|
1 334 219 USD
|
|
